These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 12654602)

  • 1. Family history and cardiovascular risk in familial hypercholesterolemia: data in more than 1000 children.
    Wiegman A; Rodenburg J; de Jongh S; Defesche JC; Bakker HD; Kastelein JJ; Sijbrands EJ
    Circulation; 2003 Mar; 107(11):1473-8. PubMed ID: 12654602
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low-density lipoprotein receptor gene mutations and cardiovascular risk in a large genetic cascade screening population.
    Umans-Eckenhausen MA; Sijbrands EJ; Kastelein JJ; Defesche JC
    Circulation; 2002 Dec; 106(24):3031-6. PubMed ID: 12473547
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In pediatric familial hypercholesterolemia, lipoprotein(a) is more predictive than LDL-C for early onset of cardiovascular disease in family members.
    Zawacki AW; Dodge A; Woo KM; Ralphe JC; Peterson AL
    J Clin Lipidol; 2018; 12(6):1445-1451. PubMed ID: 30150142
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inborn coagulation factors are more important cardiovascular risk factors than high LDL-cholesterol in familial hypercholesterolemia.
    Ravnskov U; de Lorgeril M; Kendrick M; Diamond DM
    Med Hypotheses; 2018 Dec; 121():60-63. PubMed ID: 30396495
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lipid and lipoprotein parameters for detection of familial hypercholesterolemia in childhood. The DECOPIN Project.
    Plana N; Rodríguez-Borjabad C; Ibarretxe D; Ferré R; Feliu A; Caselles A; Masana L;
    Clin Investig Arterioscler; 2018; 30(4):170-178. PubMed ID: 29602595
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differences in characteristics and risk of cardiovascular disease in familial hypercholesterolemia patients with and without tendon xanthomas: a systematic review and meta-analysis.
    Oosterveer DM; Versmissen J; Yazdanpanah M; Hamza TH; Sijbrands EJ
    Atherosclerosis; 2009 Dec; 207(2):311-7. PubMed ID: 19439299
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Progress in the care of familial hypercholesterolaemia: 2016.
    Bell DA; Watts GF
    Med J Aust; 2016 Sep; 205(5):232-6. PubMed ID: 27581271
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Achieving low-density lipoprotein cholesterol targets as assessed by different methods in patients with familial hypercholesterolemia: an analysis from the HELLAS-FH registry.
    Rizos CV; Florentin M; Skoumas I; Tziomalos K; Rallidis L; Kotsis V; Athyros V; Skalidis E; Kolovou G; Garoufi A; Bilianou E; Koutagiar I; Agapakis D; Kiouri E; Antza C; Katsiki N; Zacharis E; Attilakos A; Sfikas G; Anagnostis P; Panagiotakos DB; Liberopoulos EN
    Lipids Health Dis; 2020 May; 19(1):114. PubMed ID: 32466791
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lipoprotein-associated phospholipase A₂ activity is increased in patients with definite familial hypercholesterolemia compared with other forms of hypercholesterolemia.
    Mattina A; Rosenbaum D; Bittar R; Bonnefont-Rousselot D; Noto D; Averna M; Bruckert E; Giral P
    Nutr Metab Cardiovasc Dis; 2018 May; 28(5):517-523. PubMed ID: 29525223
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Why patients with familial hypercholesterolemia are at high cardiovascular risk? Beyond LDL-C levels.
    Bianconi V; Banach M; Pirro M;
    Trends Cardiovasc Med; 2021 May; 31(4):205-215. PubMed ID: 32205033
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnosis of heterozygous familial hypercholesterolemia. DNA analysis complements clinical examination and analysis of serum lipid levels.
    Koivisto PV; Koivisto UM; Miettinen TA; Kontula K
    Arterioscler Thromb; 1992 May; 12(5):584-92. PubMed ID: 1315570
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polygenic risk score predicts prevalence of cardiovascular disease in patients with familial hypercholesterolemia.
    Paquette M; Chong M; Thériault S; Dufour R; Paré G; Baass A
    J Clin Lipidol; 2017; 11(3):725-732.e5. PubMed ID: 28456682
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhanced status of inflammation and endothelial activation in subjects with familial hypercholesterolaemia and their related unaffected family members: a case control study.
    Rahman T; Hamzan NS; Mokhsin A; Rahmat R; Ibrahim ZO; Razali R; Thevarajah M; Nawawi H
    Lipids Health Dis; 2017 Apr; 16(1):81. PubMed ID: 28438163
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The molecular genetic basis and diagnosis of familial hypercholesterolemia in Denmark.
    Jensen HK
    Dan Med Bull; 2002 Nov; 49(4):318-45. PubMed ID: 12553167
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical phenotype in relation to the distance-to-index-patient in familial hypercholesterolemia.
    Besseling J; Huijgen R; Martin SS; Hutten BA; Kastelein JJ; Hovingh GK
    Atherosclerosis; 2016 Mar; 246():1-6. PubMed ID: 26745182
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transition from LDL apheresis to evolocumab in heterozygous FH is equally effective in lowering LDL, without lowering HDL cholesterol.
    Lappegård KT; Enebakk T; Thunhaug H; Hovland A
    Atherosclerosis; 2016 Aug; 251():119-123. PubMed ID: 27318831
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selective screening for familial hypercholesterolemia in Austrian children - first year results.
    Kreissl A; Walleczek N; Espina PR; Hallwirth U; Greber-Platzer S
    BMC Pediatr; 2019 Jun; 19(1):208. PubMed ID: 31238984
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence and significance of cardiovascular risk factors in a large cohort of patients with familial hypercholesterolaemia.
    de Sauvage Nolting PR; Defesche JC; Buirma RJ; Hutten BA; Lansberg PJ; Kastelein JJ
    J Intern Med; 2003 Feb; 253(2):161-8. PubMed ID: 12542556
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of low-density lipoprotein receptor mutation on lipoproteins and cardiovascular disease risk: a parent-offspring study.
    Koeijvoets KC; Wiegman A; Rodenburg J; Defesche JC; Kastelein JJ; Sijbrands EJ
    Atherosclerosis; 2005 May; 180(1):93-9. PubMed ID: 15823280
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PCSK9 R46L, lower LDL, and cardiovascular disease risk in familial hypercholesterolemia: a cross-sectional cohort study.
    Saavedra YG; Dufour R; Davignon J; Baass A
    Arterioscler Thromb Vasc Biol; 2014 Dec; 34(12):2700-5. PubMed ID: 25278291
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.